Home › Stocks › PLRX › All Fund Holders
PLRX — PLIANT THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 37 · Reported value held: $38.42M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Casdin Capital history | Q2 2024 | 1.00M | $10.75M | 0.82% | Hold |
| Harvard Management Company history | Q1 2023 | 281.19K | $7.48M | 0.80% | Reduce |
| Vanguard Group history | Q4 2025 | 2.82M | $3.44M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 2.26M | $2.58M | 0.00% | Hold |
| Citadel Advisors history | Q2 2026 | 2.14M | $2.44M | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2026 | 2.05M | $2.34M | 0.00% | Add |
| Prudential Financial history | Q1 2023 | 54.30K | $1.44M | 0.00% | Reduce |
| BlackRock Inc history | Q2 2026 | 1.15M | $1.31M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 835.12K | $952.04K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q2 2026 | 681.65K | $783.89K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 578.58K | $659.95K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 571.76K | $651.81K | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 559.45K | $637.77K | 0.00% | Reduce |
| Moore Capital Management history | Q2 2023 | 27.00K | $489.24K | 0.01% | New |
| Bank of America Corp history | Q1 2026 | 352.71K | $444.41K | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2024 | 31.91K | $343.03K | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 298.98K | $340.83K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2025 | 251.37K | $291.58K | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 208.59K | $237.79K | 0.00% | Reduce |
| Northern Trust Corp history | Q2 2026 | 125.06K | $142.57K | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 104.68K | $119.33K | 0.00% | Reduce |
| D. E. Shaw & Co history | Q2 2024 | 10.68K | $114.80K | 0.00% | New |
| CPP Investments history | Q4 2025 | 61.40K | $74.91K | 0.00% | New |
| Legal & General Investment Management America history | Q1 2025 | 52.96K | $71.69K | 0.00% | Hold |
| Deutsche Bank AG history | Q1 2025 | 47.47K | $64.09K | 0.00% | Reduce |
| AQR Capital Management history | Q2 2025 | 53.68K | $62.27K | 0.00% | Reduce |
| Franklin Resources history | Q1 2025 | 35.58K | $48.04K | 0.00% | Reduce |
| Manulife Financial history | Q1 2025 | 21.22K | $28.65K | 0.00% | Reduce |
| Janus Henderson Group history | Q1 2025 | 17.25K | $25.27K | 0.00% | Hold |
| Point72 Asset Management history | Q2 2026 | 20.07K | $22.88K | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 16.03K | $18.28K | 0.00% | Add |
| Citigroup Inc history | Q3 2025 | 4.32K | $6.39K | 0.00% | Reduce |
| PNC Financial Services history | Q4 2025 | 978 | $1.19K | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | Q2 2026 | 419 | $478 | 0.00% | Reduce |
| Amundi US history | Q1 2025 | 138 | $181 | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2025 | 83.87K | $98 | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2026 | 50 | $57 | 0.00% | Hold |